海外の治験の状況「1」での検索結果
1245件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Periodontal and Salivary Evaluation of Type 1 Diabetes Mellitus Patients
- Diabetes Mellitus, Type 1;Periodontal Diseases;Diabetes Mellitus, Type 1;Periodontal Diseases
- Brazil
- 2016-09-29
Not Recruiting
- To study the impact of age-patient-related, treatment-related, behavior and structure of care-related variables on glycemic control and quality of life in children, adolescents and young adults with type-1 diabetes mellitus
- Type 1 diabetes mellitus without complications
- Algeria, Argentina, Denmark, Egypt, France, Germany, Hungary, India, Italy, Jordan, Lebanon, Mexico, Morocco, Portugal, Romania, Russian Federation, Slovenia, South Africa, Spain, Sweden, United States of America
- 2012-08-28
Not recruiting
- Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Argentina, Brazil, Bulgaria, Canada, Chile, Czech Republic, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Latvia, Macedonia, The Former Yugoslav Republic of, Mexico, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, United Kingdom, United States
- 2016-03-30
Recruiting
- A PHASE 1/2 DOSE ESCALATION SAFETY, PHARMACOKINETIC AND EFFICACY STUDY OF MULTIPLE INTRAVENOUS ADMINISTRATIONS OF A HUMANIZED MONOCLONAL ANTIBODY (SAR650984) AGAINST CD38 IN PATIENTS WITH SELECTED CD38+ HEMATOLOGICAL MALIGNANCIES
- -C900 Multiple myeloma Multiple myeloma;Multiple myeloma
- Argentina, Austria, Belgium, Brazil, Chile, Colombia, Finland, Greece, Israel, Italy, Mexico, Russian Federation, Spain, Turkey, Ukraine, United Kindgdom, United States
- 2017-02-09
Authorised
- Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients with Selected CD38+ Hematological Malignancies
- Haematological malignancy MedDRA version: 20.0 Level: PT Classification code 10066476 Term: Haematological malignancy System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Belgium, Brazil, Chile, Colombia, Finland, Greece, Israel, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, Ukraine, United Kingdom, United States
- 2016-11-04
Authorised
- Comparison of the Safety and Efficacy of HOE901-U300 with Lantus in Children and Adolescents with Type 1 Diabetes Mellitus
- Type 1 diabetes mellitus br>MedDRA version: 19.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Argentina, Brazil, Canada, Chile, Czech Republic, France, Germany, Hungary, Israel, Italy, Japan, Latvia, Mexico, Poland, Romania, Russian Federation, Spain, United Kingdom, United States
- 2016-03-01
Authorised
- Phase 2/3 study of rogaratinib (pan FGFR inhibitor) vs chemotherapy in patients with locally advanced or metastatic urothelial carcinoma with a high amount of specific cell growth factor receptors 1 and 3 (FGFR1 and 3) in the tumor cells
- mRNA FGF receptor 1 and 3 positive locally advanced or metastatic urothelial carcinoma progressed after prior platinum-containing chemotherapy MedDRA version: 20.0 Level: LLT Classification code 10064467 Term: Urothelial carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Democratic People's Republic of, Netherlands, Poland, Portugal, Russian Federation, Singapore, Slovakia, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2018-01-18
Recruiting
- Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Brazil
- 2019-04-05
Not Recruiting
- Effect of insulin therapy and dietary adjustments on performance during simulated soccer tests in people with type 1 diabetes
- Type 1 diabetes Nutritional, Metabolic, Endocrine Type 1 diabetes
- Costa Rica
- 2017-01-05
Not Recruiting
- PHASE I STUDY OF THE COMBINATION OF TRASTUZUMAB EMTANSINE (T-DM1) AND CAPECITABINE IN HER2-POSITIVE METASTATIC BREAST CANCER AND HER2-POSITIVE LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER PATIENTS, FOLLOWED BY A RANDOMIZED, OPEN-LABEL PHASE II STUDY OF TRASTUZUMAB EMTANSINE AND CAPECITABINE VERSUS TRASTUZUMAB EMTANSINE ALONE IN HER2-POSITIVE METASTATIC BREAST CANCER
- -C50 Malignant neoplasm of breast Malignant neoplasm of breast;Malignant neoplasm of breast
- Argentina, Brazil, Canada, France, Germany, Greece, Italy, Liberia, Portugal, Russian Federation, Serbia, Slovakia, Spain
- 2015-05-12